.Ali Rezaie MD MSc & team publish in Gastroenterology that GLP-1s increase the risk of aspiration pneumonia after endoscopy by 33%

American Gastroenterological Association (AGA) continues to suggest an individual approach to decide if a patient should stop GLP-1s before endoscopic procedures

ow.ly/CaNo50RpxxI

When it comes to management of complex diseases such as SIBO, ChatGPT4 fails to provide accurate treatment plans.

AI still has a long way to go to provide acceptable advice when disease management is non-algorithmic.
#ibsawarenessmonth
wjgnet.com/2644-3236/full…

Foundational work by Mark Pimentel MD, MAST Research Program, Gabriela Leite, PhD, Ali Rezaie MD MSc
PMID: 32140945- pubmed.ncbi.nlm.nih.gov/32140945/
PMID: 37315761- pubmed.ncbi.nlm.nih.gov/37315761/
13/n

On the heels of #worldibsday it is important to thank the people in our GI motility program who are on the front lines taking care of people with #IBS and IBS research Bianca Chang Jane Lim Ali Rezaie MD MSc Amrit Kamboj, MD, Dr. Yin Chan and Coka Yip. Cedars-Sinai Academic Medicine

Management of SIBO was one of the top clinical questions of the members of the American College of Physicians in 2024.
Covering that topic along with organic causes of IBS-like symptoms at the #IM2024 conference in Boston.
#WorldIBSDay2024

A big leap in strengthening the concept of weight management via microbiome modulation!

Specific bacteria in the small bowel decrease or increase in relation to weight.

Today all major Iranian cities suffered a massive crack down by the #IRGC forces. An ominous sign of an imminent all-out war!

Let there be peace but that won't happen unless the Islamic regime of Iran falls

An extreme case of buried bumper syndrome associated with sepsis!

Had to pass a guidewire and pull the PEG externally. Reused the tract for a low-profile gastrostomy feeding tube.

MAST investigator & gastroenterologist Ali Rezaie MD MSc said it best. The main issue in #IBS treatment currently is 'defining the disease only based on symptoms... The key will be to find #biomarkers for each patient'. ( #microbiome , food sensitivities, dysmotility, etc)…

While great advances have been made in IBS since this tweet, specially re microbiome, advances in the next five years will change how we define, diagnose and individually treat each IBS patient.
MAST Research Program

Happy #IBSAwarenessMonth

And yet another study published in AJG - The American Journal of Gastroenterology showing increased gastric residue on EGD in patients treated with GLP1-RAs
journals.lww.com/ajg/abstract/9…

Great prospective study in JAMA Surgery showing GLP1-RAs & tirzepatide increase the risk of excessive fasting stomach contents by 30% using gastric ultrasound.

Their results jive very nicely with ours.

jamanetwork.com/journals/jamas…